Axonics (AXNX) Stock Analysis

What Axonics does

Axonics, Inc. is a medical device firm that focuses on developing and bringing to market sacral neuromodulation (SNM) solutions. These advanced SNM systems are designed to address a range of medical conditions, such as overactive bladder (including urinary urge incontinence and frequent urges to urinate), alongside fecal incontinence and non-obstructive urinary retention. The company's flagship rechargeable SNM System, known as r-SNM, operates by delivering gentle electrical impulses to specific sacral nerves, aiming to restore regular communication between the brain and the bladder or bowel, thereby lessening the symptoms of their dysfunction. Beyond its SNM portfolio, Axonics also provides Bulkamid, a urethral bulking agent for managing stress urinary incontinence in women. The firm distributes its offerings both through its dedicated sales team and a network of distributors across the United States, the United Kingdom, Germany, the Netherlands, the Nordic region, and other international markets. Established in 2012 and headquartered in Irvine, California, the company was initially known as Axonics Modulation Technologies, Inc., before officially changing its name to Axonics, Inc. in March 2021.

Key metrics

ETFs linked to AXNX

Broad-market and Healthcare sector ETFs an investor holding Axonics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AXNX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Axonics?

Axonics trades under the ticker AXNX on NASDAQ.

Which exchange is AXNX listed on?

AXNX is listed on NASDAQ.

What sector does Axonics operate in?

Axonics is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze AXNX in a portfolio?

PortView shows AXNX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.